ClinicalTrials.gov
ClinicalTrials.gov Menu

Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill (VASTVALUS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01073800
Recruitment Status : Completed
First Posted : February 23, 2010
Last Update Posted : December 16, 2011
Sponsor:
Information provided by (Responsible Party):
University of Alberta

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2009
  Actual Study Completion Date : September 2011